ArticleJournal of neurology2024

Comparing major and mild cognitive impairment risks in older type-2 diabetic patients: a Danish register-based study on dipeptidyl peptidase-4 inhibitors vs. glucagon-like peptide-1 analogues.

Vera Battini et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.